Page last updated: 2024-09-05

sb 203580 and az 11645373

sb 203580 has been researched along with az 11645373 in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(az 11645373)
Trials
(az 11645373)
Recent Studies (post-2010) (az 11645373)
3,48941,13722016

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)az 11645373 (IC50)
P2X purinoceptor 7Homo sapiens (human)0.031

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldwin, SA; Caseley, EA; Fishwick, CW; Jiang, LH; Muench, SP; Simmons, K1

Other Studies

1 other study(ies) available for sb 203580 and az 11645373

ArticleYear
Docking of competitive inhibitors to the P2X7 receptor family reveals key differences responsible for changes in response between rat and human.
    Bioorganic & medicinal chemistry letters, 2015, Aug-15, Volume: 25, Issue:16

    Topics: Adenosine Triphosphate; Amino Acid Sequence; Animals; Binding Sites; Humans; Molecular Docking Simulation; Molecular Sequence Data; Protein Structure, Tertiary; Purinergic P2X Receptor Antagonists; Rats; Receptors, Purinergic P2X7; Sequence Alignment

2015